4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Mirror Neurons in Older Participants (MNOP)

Mirror Neurons in Older Participants (MNOP)

Study Description
Brief Summary:
A critical problem facing aging adults is muscle weakness. Whereas scientists have traditionally attributed the loss of muscle strength with aging to muscle atrophy, emerging evidence suggests that impairments in the neuromuscular system's ability to voluntarily generate force plays a more central role than previously appreciated. One area that has not yet been investigated includes the role that observing another's actions - thereby activating mirror neurons - plays in muscle force generation. Therefore, the purpose of this study is to examine the acute effects of action observation on muscular strength, voluntary muscle activation, and cortical excitability and inhibition in older adults.

Condition or disease Intervention/treatment Phase
Muscle Weakness Dynapenia Sarcopenia Other: Action Observation Not Applicable

Detailed Description:
A critical problem facing aging adults is muscle weakness. Whereas scientists have traditionally attributed the loss of muscle strength with aging to atrophic effects, emerging evidence suggests that impairments in the neuromuscular system's ability to voluntarily generate force plays a more central role than previously appreciated. One area that has not yet been investigated includes the role that observing another's actions - thereby activating mirror neurons - plays in muscle force generation. Therefore, the purpose of this study is to examine the acute effects of action observation on muscular strength, voluntary activation, and cortical excitability and inhibition in older adults. Following a thorough familiarization visit, twenty-five men and women ≥60 years of age will complete three action observation sessions in a randomized, counterbalanced manner: 1) observation of very strong hand/wrist contractions, 2) observation of very weak hand/wrist contractions, and 3) a control condition. Maximal voluntary contractions (MVCs) of the wrist flexors will be performed before and after observation sessions. Percent voluntary activation will be determined via the interpolated twitch technique. Single-pulse transcranial magnetic stimulation (TMS) and electromyographic (EMG) recordings from the flexor carpi radialis and first dorsal interosseous will be used to quantify cortical excitability and inhibition, via motor evoked potential amplitude and silent period duration, respectively. The hypothesis of this study is that observation of strong muscle contractions will acutely increase muscle strength, and such changes will be facilitated by enhanced corticospinal excitability and decreased inhibition. In contrast, it is hypothesized that observation of very weak contractions will cause no such efforts or even acute muscle weakness. Collectively, we propose that manipulation of mirror neurons is a worthwhile strategy for clinicians hoping to induce neuromuscular adaptations in older adults, particularly in settings where movement of a joint is painful or infeasible (e.g., bedrest or immobilization).
Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 25 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Mirror Neurons in Older Participants (Project MNOP): Acute Effects of Action Observation on Muscle Strength/Weakness and Neurophysiological Factors in Older Adults
Actual Study Start Date : December 20, 2018
Estimated Primary Completion Date : December 1, 2021
Estimated Study Completion Date : April 1, 2022
Arms and Interventions
Arm Intervention/treatment
Muscle strength condition Other: Action Observation
Strength, voluntary activation, and cortical responses to three conditions will be measured: 1) action observation of very strong, forceful contractions of the hand and wrist flexors 2) action observation of very weak, feeble contractions of the hand and wrist flexors 3) no action observation. Experimental conditions will be randomized and counterbalanced.

Muscle weakness condition Other: Action Observation
Strength, voluntary activation, and cortical responses to three conditions will be measured: 1) action observation of very strong, forceful contractions of the hand and wrist flexors 2) action observation of very weak, feeble contractions of the hand and wrist flexors 3) no action observation. Experimental conditions will be randomized and counterbalanced.

No Intervention: Control
Outcome Measures
Primary Outcome Measures :
  1. Muscle Strength [ Time Frame: 5 minutes ]
    Isometric muscle strength of the non-dominant hand and wrist flexors will be assessed during maximal voluntary contractions (MVCs).


Secondary Outcome Measures :
  1. Voluntary Activation [ Time Frame: 5 minutes ]
    Percent voluntary activation will be quantified during the MVCs to determine each participant's ability to maximally activate their wrist flexor muscles voluntarily.

  2. Corticospinal excitability [ Time Frame: 5 minutes ]
    Transcranial magnetic stimulation will be used to quantify corticospinal excitability throughout the study.


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy men and women ≥60 years of age

Exclusion Criteria:

  • Neuromuscular disease (e.g. Parkinson's, MS, ALS)
  • Metabolic disease (e.g. diabetes, thyroid disorder, metabolic syndrome)
  • Arthritis in the upper limbs (hands, arms, shoulders)
  • Trouble using or controlling one's muscles
  • History of cancer
  • History of stroke
  • History of heart attack
  • Use of an assistive walking device or other mobility aids
  • Physician mandated contraindication to exercise within the last 6 months
  • Epilepsy or history of convulsions/seizures
  • History of fainting or syncope
  • History of head trauma that was diagnosed as concussion or was associated with loss of consciousness
  • History of hearing problems or tinnitus
  • Cochlear implants
  • Implanted metal in the brain, skull, or elsewhere in the body
  • Implanted neurotransmitter
  • Cardiac pacemaker or intracardiac lines
  • Medication infusion device
  • Past problems with brain stimulation
  • Past problems with MRI
  • Use of muscle relaxants or benzodiazepines
  • Allergy to rubbing alcohol
  • Any other health related illnesses that would prohibit a participant from physical performance testing
  • Lack of transportation to and from the laboratory
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Kylie K. Harmon, M.S. (407)823-0600 kharmon@knights.ucf.edu
Contact: Ryan M. Girts (407)823-0600 ryangirts@knights.ucf.edu

Locations
Layout table for location information
United States, Florida
UCF Neuromuscular Plasticity Laboratory Recruiting
Orlando, Florida, United States, 32826
Contact: Matt S. Stock, Ph.D.    407-823-0600    matt.stock@ucf.edu   
Sponsors and Collaborators
University of Central Florida
Investigators
Layout table for investigator information
Principal Investigator: Matt S. Stock, Ph.D. University of Central Florida
Tracking Information
First Submitted Date  ICMJE May 8, 2019
First Posted Date  ICMJE May 13, 2019
Last Update Posted Date April 29, 2021
Actual Study Start Date  ICMJE December 20, 2018
Estimated Primary Completion Date December 1, 2021   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: May 9, 2019)
Muscle Strength [ Time Frame: 5 minutes ]
Isometric muscle strength of the non-dominant hand and wrist flexors will be assessed during maximal voluntary contractions (MVCs).
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: May 9, 2019)
  • Voluntary Activation [ Time Frame: 5 minutes ]
    Percent voluntary activation will be quantified during the MVCs to determine each participant's ability to maximally activate their wrist flexor muscles voluntarily.
  • Corticospinal excitability [ Time Frame: 5 minutes ]
    Transcranial magnetic stimulation will be used to quantify corticospinal excitability throughout the study.
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Mirror Neurons in Older Participants
Official Title  ICMJE Mirror Neurons in Older Participants (Project MNOP): Acute Effects of Action Observation on Muscle Strength/Weakness and Neurophysiological Factors in Older Adults
Brief Summary A critical problem facing aging adults is muscle weakness. Whereas scientists have traditionally attributed the loss of muscle strength with aging to muscle atrophy, emerging evidence suggests that impairments in the neuromuscular system's ability to voluntarily generate force plays a more central role than previously appreciated. One area that has not yet been investigated includes the role that observing another's actions - thereby activating mirror neurons - plays in muscle force generation. Therefore, the purpose of this study is to examine the acute effects of action observation on muscular strength, voluntary muscle activation, and cortical excitability and inhibition in older adults.
Detailed Description A critical problem facing aging adults is muscle weakness. Whereas scientists have traditionally attributed the loss of muscle strength with aging to atrophic effects, emerging evidence suggests that impairments in the neuromuscular system's ability to voluntarily generate force plays a more central role than previously appreciated. One area that has not yet been investigated includes the role that observing another's actions - thereby activating mirror neurons - plays in muscle force generation. Therefore, the purpose of this study is to examine the acute effects of action observation on muscular strength, voluntary activation, and cortical excitability and inhibition in older adults. Following a thorough familiarization visit, twenty-five men and women ≥60 years of age will complete three action observation sessions in a randomized, counterbalanced manner: 1) observation of very strong hand/wrist contractions, 2) observation of very weak hand/wrist contractions, and 3) a control condition. Maximal voluntary contractions (MVCs) of the wrist flexors will be performed before and after observation sessions. Percent voluntary activation will be determined via the interpolated twitch technique. Single-pulse transcranial magnetic stimulation (TMS) and electromyographic (EMG) recordings from the flexor carpi radialis and first dorsal interosseous will be used to quantify cortical excitability and inhibition, via motor evoked potential amplitude and silent period duration, respectively. The hypothesis of this study is that observation of strong muscle contractions will acutely increase muscle strength, and such changes will be facilitated by enhanced corticospinal excitability and decreased inhibition. In contrast, it is hypothesized that observation of very weak contractions will cause no such efforts or even acute muscle weakness. Collectively, we propose that manipulation of mirror neurons is a worthwhile strategy for clinicians hoping to induce neuromuscular adaptations in older adults, particularly in settings where movement of a joint is painful or infeasible (e.g., bedrest or immobilization).
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Condition  ICMJE
  • Muscle Weakness
  • Dynapenia
  • Sarcopenia
Intervention  ICMJE Other: Action Observation
Strength, voluntary activation, and cortical responses to three conditions will be measured: 1) action observation of very strong, forceful contractions of the hand and wrist flexors 2) action observation of very weak, feeble contractions of the hand and wrist flexors 3) no action observation. Experimental conditions will be randomized and counterbalanced.
Study Arms  ICMJE
  • Muscle strength condition
    Intervention: Other: Action Observation
  • Muscle weakness condition
    Intervention: Other: Action Observation
  • No Intervention: Control
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Recruiting
Estimated Enrollment  ICMJE
 (submitted: May 9, 2019)
25
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE April 1, 2022
Estimated Primary Completion Date December 1, 2021   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Healthy men and women ≥60 years of age

Exclusion Criteria:

  • Neuromuscular disease (e.g. Parkinson's, MS, ALS)
  • Metabolic disease (e.g. diabetes, thyroid disorder, metabolic syndrome)
  • Arthritis in the upper limbs (hands, arms, shoulders)
  • Trouble using or controlling one's muscles
  • History of cancer
  • History of stroke
  • History of heart attack
  • Use of an assistive walking device or other mobility aids
  • Physician mandated contraindication to exercise within the last 6 months
  • Epilepsy or history of convulsions/seizures
  • History of fainting or syncope
  • History of head trauma that was diagnosed as concussion or was associated with loss of consciousness
  • History of hearing problems or tinnitus
  • Cochlear implants
  • Implanted metal in the brain, skull, or elsewhere in the body
  • Implanted neurotransmitter
  • Cardiac pacemaker or intracardiac lines
  • Medication infusion device
  • Past problems with brain stimulation
  • Past problems with MRI
  • Use of muscle relaxants or benzodiazepines
  • Allergy to rubbing alcohol
  • Any other health related illnesses that would prohibit a participant from physical performance testing
  • Lack of transportation to and from the laboratory
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 60 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE
Contact: Kylie K. Harmon, M.S. (407)823-0600 kharmon@knights.ucf.edu
Contact: Ryan M. Girts (407)823-0600 ryangirts@knights.ucf.edu
Listed Location Countries  ICMJE United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03946709
Other Study ID Numbers  ICMJE SBE-18-14657
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Responsible Party Matt Stock, University of Central Florida
Study Sponsor  ICMJE University of Central Florida
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Principal Investigator: Matt S. Stock, Ph.D. University of Central Florida
PRS Account University of Central Florida
Verification Date April 2021

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP